Market Price

1.75 

0.02 1.2%

as of Nov 13 '18

52 Week Range:

1.53 11.98


Stock Analyzer Tutorials

S2O Stock Analyzer - General Info

General Info


type: video (mp4); length: 3:30

Demonstrates how to use Stock Analyzer, shows how to analyze a stock and explains in detail "General Info" section of the Stock Analyzer result page.

S2O Stock Analyzer - Financial Statements

Financial Statements


type: video (mp4); length: 5:10

Explains information presented in the Financial Statements section of the S2O Stock Analyzer: financial statements charts, absolute values and growth rates.

S2O Stock Analyzer - Growth Grade and Financial Ratios

Growth Grade and Financial Ratios


type: video (mp4); length: 5:09

Demonstrates how to use Growth Grade & Financial Ratios section; shows the difference between historical and year-over-year Growth Grade on the real life example.

S2O Stock Analyzer - Value Price

Value Price


type: video (mp4); length: 6:03

Demonstrates how to use Value Price (intrinsic value) and the Graham Number, MOS (margin of safety) and IRT - Investment Recovery Time; explains 3 different projection models used to compute value price - pessimistic, moderate and optimistic.

S2O Stock Analyzer - Price Charts

Price Charts


type: video (mp4); length: 8:34

Demonstrates basic rules of how to read a candlestick chart, long and short term moving averages, stochastic, MACD and relative strength (RS) charts. Explains how bull or bear market condition is computed.

General Info

Aceto Corporation engages in the development, marketing, sale, and distribution of finished dosage form generic pharmaceuticals, nutraceutical products, pharmaceutical active ingredients and intermediates, specialty performance chemicals, and agricultural protection products. The company operates in three segments: Human Health, Pharmaceutical Ingredients, and Performance Chemicals. The Human Health segment supplies raw materials used in the production of nutritional and packaged dietary supplements, including vitamins, amino acids, iron compounds, and biochemicals used in pharmaceutical and nutritional preparations. This segment is also involved in developing and marketing generic pharmaceutical products. It sells its generic prescription and over-the-counter pharmaceutical products to wholesalers, chain drug stores, distributors, and mass merchandisers. The Pharmaceutical Ingredients segment offers active pharmaceutical ingredients and pharmaceutical intermediates to various generic drug companies. The Performance Chemicals segment provides specialty chemicals for use in the manufacture of plastics, surface coatings, cosmetics and personal care, textiles, and fuels and lubricants, as well as for food, flavor, paper, and film industries; dye and pigment intermediates used in the color-producing industries; and organic intermediates used in the production of agrochemicals. Its raw materials are also used in electronic parts for photo tooling, circuit boards, and production of computer chips. This segment also offers agricultural protection products comprising herbicides, fungicides, and insecticides, which control weed growth and the spread of insects and microorganisms; and sprout inhibitors for potatoes. The company serves various companies in the industrial chemical, agricultural, and human health and pharmaceutical industries primarily in the United States, Europe, and Asia. Aceto Corporation was founded in 1947 and is headquartered in Port Washington, New York.

Financial Statements

The charts below show selected Annual and Quarterly Financial Data.

The purpose of these charts is to discover long and short term change dynamics. When numbers are growing year after year in the annual statements chart, the business become stronger and stronger and this is a good sign.

Quarterly Data Chart can be used to do a short term analysis. It makes sense to pay attention to the quarterly dynamics and do not wait for the next yearly statement. We should be alerted if we see that quarterly numbers are going down.

You can check "Annual Financial Statements" and "Quarterly Financial Statements" sections for exact numbers and growth rates.

Annual Statements

On a charts below the Line shows absolute values and the Bar chart shows Year-Over-Year Growth Rate for selected financial statement item. A consistent GROWTH is generally considered necessary to fund future growth from within a business.
NOTE: Growth Rate is not provided if either the latest period or the year-ago period contains a net loss. (source: WSJ Digest of Earnings)
TIP! move your mouse pointer over bar or a circle on any chart below to see details.

Financial Statements

Income Statement



 

Cash Flow Statement



 

Balance Sheet



 

Liquidity Ratios

Current Ratio


 

Current Ratio measures the ability to meet short term obligations. Generally accepted standard is 2 (current assets should be 2 times or 200% of current liabilities).

Quick Ratio


 

Measures immediate liquidity or the cash available to cover immediate liabilities. A safe margin would be at least 1 (100%).

Financial Leverage


 

Defined as total assets divided by total shareholders' equity. The higher the ratio, the more debt a company uses in its capital structure.

Profitability Ratios

ROA


 

Return on Assets (ROA) measures the income (profit) that is generated by the use of the assets of the business.

ROE


 

Return on Equity (ROE) is a measure of profitability that calculates how many dollars of profit a company generates with each dollar of shareholders equity. ROE is sometimes called "return on net worth."

ROIC


 

The Return on Invested Capital (ROIC) measure gives a sense of how well a company is using its money to generate returns. Some investors use this figure as a final evaluation to determine whether or not to invest in a company.

Annual Statements

Item Name Jun '08 Jun '09 Jun '10 Jun '11 Jun '12 Jun '13 Jun '14 Jun '15 Jun '16 Jun '17 Jun '18
Equity (BVPS) 5.75
5.72
5.49
6.04
6.26
6.65
7.76
8.25
10.10
13.36
6.61
growth rate -0.5% -4.0% 10.0% 3.6% 6.2% 16.7% 6.3% 22.4% 32.3% -50.5%
Earnings BIT 22.19
12.73
10.20
16.96
24.74
34.55
44.27
48.86
58.13
44.17
-17.20
growth rate -42.6% -19.9% 66.3% 45.9% 39.7% 28.1% 10.4% 19.0% -24.0% -100.0%
Avg.PE 14.14
19.31
21.98
19.53
14.27
17.12
17.86
26.51
16.95
20.25
52.79
growth rate 36.6% 13.8% -11.2% -26.9% 20.0% 4.3% 48.4% -36.1% 19.5% 160.7%
ROA 6.56
4.04
3.01
3.30
5.56
7.17
7.33
6.99
6.75
1.44
-34.97
growth rate -38.4% -25.5% 9.6% 68.5% 29.0% 2.2% -4.6% -3.4% -78.7% -100.0%
ROE 10.16
6.12
4.68
5.97
10.33
12.31
13.54
13.73
12.45
3.20
-125.71
growth rate -39.8% -23.5% 27.6% 73.0% 19.2% 10.0% 1.4% -9.3% -74.3% -100.0%
ROIC 9.62
5.42
4.06
5.32
8.69
10.71
10.68
10.17
9.92
3.64
-50.63
growth rate -43.7% -25.1% 31.0% 63.4% 23.3% -0.3% -4.8% -2.5% -63.3% -100.0%
Cur. Ratio 2.98
3.66
2.62
2.39
2.61
2.43
2.33
2.48
3.57
2.13
1.66
growth rate 22.8% -28.4% -8.8% 9.2% -6.9% -4.1% 6.4% 44.0% -40.3% -22.1%
Quick Ratio 1.85
2.44
1.57
1.43
1.41
1.45
1.44
1.68
2.51
1.50
1.19
growth rate 31.9% -35.7% -8.9% -1.4% 2.8% -0.7% 16.7% 49.4% -40.2% -20.7%
Leverage 1.58
1.45
1.66
1.93
1.78
1.66
2.00
1.93
1.78
2.55
8.05
growth rate -8.2% 14.5% 16.3% -7.8% -6.7% 20.5% -3.5% -7.8% 43.3% 215.7%
Balance Sheet Jun '08 Jun '09 Jun '10 Jun '11 Jun '12 Jun '13 Jun '14 Jun '15 Jun '16 Jun '17 Jun '18
Acct.Receivable 0.00
0.00
74.70
83.70
78.67
96.09
127.90
172.01
177.50
289.07
256.55
growth rate 12.1% -6.0% 22.1% 33.1% 34.5% 3.2% 62.9% -11.3%
Acct.Payable 66.93
78.19
48.72
54.96
46.03
90.01
106.79
growth rate 16.8% -37.7% 12.8% -16.2% 95.5% 18.6%
Cur.Assets 193.80
171.60
195.60
198.60
191.97
218.30
276.35
310.31
350.06
488.16
502.63
growth rate -11.5% 14.0% 1.5% -3.3% 13.7% 26.6% 12.3% 12.8% 39.5% 3.0%
Total Assets 222.20
205.50
231.90
311.70
299.28
323.43
467.98
489.77
538.17
1,054.79
767.02
growth rate -7.5% 12.9% 34.4% -4.0% 8.1% 44.7% 4.7% 9.9% 96.0% -27.3%
Cash 47.06
57.80
30.90
28.70
24.86
33.23
42.90
34.02
66.83
55.68
100.87
growth rate 22.8% -46.5% -7.1% -13.4% 33.7% 29.1% -20.7% 96.4% -16.7% 81.2%
Inventory 71.11
54.40
74.90
77.40
84.69
83.85
100.68
95.60
98.11
136.39
137.08
growth rate -23.5% 37.7% 3.3% 9.4% -1.0% 20.1% -5.1% 2.6% 39.0% 0.5%
Cur.Liabilities 65.00
46.90
74.60
83.20
73.64
89.91
118.52
125.00
98.91
239.41
302.52
growth rate -27.9% 59.1% 11.5% -11.5% 22.1% 31.8% 5.5% -20.9% 142.1% 26.4%
Liabilities 81.80
63.90
92.20
150.80
131.28
128.79
234.40
235.56
236.34
649.72
671.74
growth rate -21.9% 44.3% 63.6% -13.0% -1.9% 82.0% 0.5% 0.3% 174.9% 3.4%
LT Debt 0.00
9.00
0.60
48.80
39.05
20.36
97.60
100.29
118.59
339.78
302.92
growth rate -93.3% 8,033.3% -20.0% -47.9% 379.5% 2.8% 18.3% 186.5% -10.9%
Equity 140.40
141.60
139.60
160.80
168.00
194.64
233.58
254.21
301.84
405.07
95.29
growth rate 0.9% -1.4% 15.2% 4.5% 15.9% 20.0% 8.8% 18.7% 34.2% -76.5%
Common Shares 25.00
25.00
25.00
26.00
27.00
27.00
29.00
29.00
30.00
33.00
35.00
growth rate 0.0% 0.0% 4.0% 3.9% 0.0% 7.4% 0.0% 3.5% 10.0% 6.1%
Cash Flow Statement Jun '08 Jun '09 Jun '10 Jun '11 Jun '12 Jun '13 Jun '14 Jun '15 Jun '16 Jun '17 Jun '18
Capital Expenditures 1.29
0.60
4.00
5.40
1.10
1.02
1.15
0.62
1.13
1.89
5.77
growth rate -53.5% 566.7% 35.0% -79.7% -6.9% 12.0% -46.1% 82.8% 67.8% 204.9%
Cash Dividends 6.11
4.90
5.10
5.20
5.33
6.02
6.81
6.96
7.08
7.83
6.29
growth rate -19.8% 4.1% 2.0% 2.5% 12.9% 13.1% 2.3% 1.7% 10.5% -19.7%
Cash From OA 15.42
22.50
-15.50
14.00
14.98
25.48
25.06
8.34
31.83
44.57
101.81
growth rate 45.9% -100.0% 100.0% 7.0% 70.1% -1.7% -66.7% 281.5% 40.0% 128.4%
FCF per Share 0.57
0.79
-0.93
0.25
0.60
0.70
0.60
0.55
0.23
1.32
1.80
growth rate 38.6% -100.0% 100.0% 140.0% 16.7% -14.3% -8.3% -58.2% 473.9% 36.4%
Sale Purchase of Stock 0.62
6.26
3.66
1.27
0.73
0.55
growth rate 909.2% -41.6% -65.2% -42.7% -24.4%
FCF 14.00
20.00
-24.00
7.00
11.00
21.00
23.00
6.00
19.00
39.00
95.00
growth rate 42.9% -100.0% 100.0% 57.1% 90.9% 9.5% -73.9% 216.7% 105.3% 143.6%
Income Statement Jun '08 Jun '09 Jun '10 Jun '11 Jun '12 Jun '13 Jun '14 Jun '15 Jun '16 Jun '17 Jun '18
Sales 359.60
322.60
346.60
412.40
444.39
499.69
510.18
542.94
558.52
638.32
711.36
growth rate -10.3% 7.4% 19.0% 7.8% 12.4% 2.1% 6.4% 2.9% 14.3% 11.4%
Op.Income 21.40
11.90
9.40
16.60
16.98
22.33
44.27
48.86
58.13
44.17
-17.20
growth rate -44.4% -21.0% 76.6% 2.3% 31.5% 98.3% 10.4% 19.0% -24.0% -100.0%
IBT 22.19
12.70
10.20
17.00
24.74
34.55
44.67
49.86
53.85
17.36
-292.82
growth rate -42.8% -19.7% 66.7% 45.5% 39.7% 29.3% 11.6% 8.0% -67.8% -100.0%
Net Income 13.50
8.60
6.60
9.00
16.98
22.33
29.00
30.88
34.77
11.38
-316.12
growth rate -36.3% -23.3% 36.4% 88.7% 31.5% 29.9% 6.5% 12.6% -67.3% -100.0%
EPS 0.54
0.35
0.26
0.34
0.63
0.81
1.02
1.06
1.18
0.35
-8.98
growth rate -35.2% -25.7% 30.8% 85.3% 28.6% 25.9% 3.9% 11.3% -70.3% -100.0%
Gross Profit 67.30
55.60
54.20
65.80
82.03
98.27
114.70
131.43
142.79
145.29
111.56
growth rate -17.4% -2.5% 21.4% 24.7% 19.8% 16.7% 14.6% 8.6% 1.8% -23.2%
R&D 1.57
2.83
5.22
5.94
7.94
7.90
7.93
growth rate 80.1% 84.3% 13.8% 33.6% -0.5% 0.4%

Quarterly Statements

Item Name Jun '17 Sep '17 Dec '17 Mar '18 Jun '18
Earnings BIT 11.73
11.28
3.79
-5.31
-26.96
growth rate -3.8% -66.5% -100.0% 0.0%
Balance Sheet Jun '17 Sep '17 Dec '17 Mar '18 Jun '18
Acct.Receivable 272.47
251.99
256.87
275.65
256.55
growth rate -7.5% 1.9% 7.3% -6.9%
Acct.Payable 90.01
98.01
106.74
125.08
106.79
growth rate 8.9% 8.9% 17.2% -14.6%
Cur.Assets 471.56
467.70
477.38
487.64
502.63
growth rate -0.8% 2.1% 2.2% 3.1%
Total Assets 1,038.19
1,017.97
1,014.94
831.28
767.02
growth rate -2.0% -0.3% -18.1% -7.7%
Cash 55.68
72.10
64.93
62.03
100.87
growth rate 29.5% -9.9% -4.5% 62.6%
Inventory 136.39
135.12
147.75
141.67
137.08
growth rate -0.9% 9.4% -4.1% -3.2%
Cur.Liabilities 222.81
227.15
238.61
435.20
302.52
growth rate 2.0% 5.0% 82.4% -30.5%
Liabilities 633.12
608.74
617.92
627.90
671.74
growth rate -3.9% 1.5% 1.6% 7.0%
LT Debt 339.78
317.57
312.02
128.70
302.92
growth rate -6.5% -1.8% -58.8% 135.4%
Equity 405.07
409.23
397.02
203.38
95.29
growth rate 1.0% -3.0% -48.8% -53.2%
Common Shares 0.30
0.31
0.31
0.31
0.31
growth rate 1.7% 0.7% 0.0% 0.0%
Cash Flow Statement Jun '17 Sep '17 Dec '17 Mar '18 Jun '18
Capital Expenditures 0.51
1.51
1.54
1.64
1.09
growth rate 197.0% 1.9% 6.6% -33.1%
Cash Dividends 1.89
1.94
1.99
2.00
0.36
growth rate 2.5% 3.1% 0.1% -81.8%
Cash From OA 13.02
43.97
2.94
9.51
45.39
growth rate 237.8% -93.3% 223.5% 377.3%
Sale Purchase of Stock 0.00
0.07
0.52
growth rate 7,200.0% 615.1%
FCF 12.51
42.46
1.41
7.87
44.30
growth rate 239.4% -96.7% 460.4% 462.6%
Income Statement Jun '17 Sep '17 Dec '17 Mar '18 Jun '18
Sales 194.62
185.26
171.23
186.00
168.88
growth rate -4.8% -7.6% 8.6% -9.2%
Op.Income 11.73
11.28
3.79
-5.31
-26.96
growth rate -3.8% -66.5% -100.0% 0.0%
IBT 3.00
2.14
-0.50
-263.04
-31.42
growth rate -28.8% -100.0% 0.0% 0.0%
Net Income 1.97
0.45
-13.86
-196.64
-106.08
growth rate -76.9% -100.0% 0.0% 0.0%
EPS
growth rate
Gross Profit 41.33
39.98
33.97
27.70
9.91
growth rate -3.3% -15.0% -18.5% -64.2%
R&D 2.90
1.62
2.12
2.47
1.73
growth rate -44.3% 31.4% 16.5% -30.2%

Growth Grade & Financial Ratios

All financial ratios below are calculated based on latest annual statements available and present the most up to date snapshot of a company finances.

Growth Grade

Historical Growth Grade:

E (20.20)

YOY Growth Grade:

D (46.53)

Click on buttons above for detailed yearly growth rates.

Market Ratios

Profitability Ratios

Liquidity Ratios

Efficiency Ratios

Value Price

Current EPS is negative, therefore value price cannot be calculated.

PE and EPS

Historical Current Forward
PE 52.79 -0.19 -2.02
EPS / Growth 5.4% -8.98 10.0%

Value Price & Investment Recovery Time

Read more about Stock2Own value price in Stock Market: Fundamental Analysis.

Equity Growth Rate: 1.0%

Estimates Pessimistic Moderate Optimistic My Numbers
Rate of Return 15.0%
MOS Price % 50 %
Future EPS Growth 1.0% 5.5% 5.5%
Future PE 0.01 5.47 5.47
Future EPS 0.00 0.00 0.00
Value Price
MOS %
0.00
-100.0%
0.00
-100.0%
0.00
-100.0%
MOS Price 0.00 0.00 0.00
IRT 99.00 99.00 99.00

Graham Number:

Current EPS is negative, therefore Graham Number cannot be calculated.
NOTE: The Graham Number applies only to certain types of stocks in combination with a number of other criteria.

Read more about Graham Number in Stock Market: Fundamental Analysis.

Price Chart

The functionality you are trying to reach is available to registered users only.

Login to your account or Register Now if you are not registered yet. Registration is FREE and will take only a minute.

Risk / Reward Ratios

The functionality you are trying to reach is available to registered users only.

Login to your account or Register Now if you are not registered yet. Registration is FREE and will take only a minute.